Your cart:£ 0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Ezetimibe - Vytorin, Zetia

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Vytorin

Generic Vytorin

Simvastatin Ezetimibe 10mg + 10/20mg + 10mg

Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.

More info »
£ 1.24 Buy now!
Zetia

Generic Zetia

Ezetimibe 10mg

Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy.

More info »
£ 0.73 Buy now!
Country, language and currency
Social bookmarks:
Testimonials
Thank-you for your service, everything has arrived without any hiccups
Read more »
Special Offer!

Merck Wins U.S. ZETIA(R) (ezetimibe)/ VYTORIN(R) (ezetimibe/simvastatin ... - MarketWatch (press release)
Merck Wins U
Merck & Co 1st-qtr earnings just beat expectations; wins Mylan patent dispute - The Pharma Letter
Merck & Co 1st-qtr earnings just beat expectations; wins Mylan patent disputeThe Pharma Letter'The court appropriately ruled that the patent for Zetia (ezetimibe) and Vytorin (ezetimibe and simvastatin) in the US is valid and enforceable,' said Bruce Kuhlik, executive vice president and general counsel of Merck
Investor Medical Waves - (VVUS, MRK, MYL, AMPE) - Galaxy Stocks
Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksInc
Heart health not just a numbers game - Winnipeg Free Press
Heart health not just a numbers gameWinnipeg Free PressOther popular drugs (ezetimibe, niacin, fibrates) that lower cholesterol numbers have not been shown to consistently reduce the chance of cardiovascular events
Advanced Atherosclerosis: The Heart and Beyond - Medscape
Advanced Atherosclerosis: The Heart and BeyondMedscapeThe premise of AIM-HIGH was to see if adding extended-release niacin to raise HDL cholesterol in patients who had already achieved a very low LDL cholesterol level (40 to 80 mg/dL) with simvastatin (and ezetimibe if needed) would lead to further risk
bookmark Bookmark this site
Subscribe to the News